Latest news
NRx Pharmaceuticals, Inc. to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans - Investing News NetworkInvesting News Network · Fri, 07 Aug 2026 20:41:57 GMTAclaris Therapeutics Receives Fast Track Designation for Modzatinib for Moderate to Severe Lichen Planus - Investing News NetworkInvesting News Network · Thu, 06 Aug 2026 22:56:11 GMTFDA Breakthrough Therapy Designation: What It Means For Biotech Investors? - RTTNewsRTTNews · Mon, 27 Jul 2026 07:00:00 GMTQuébec Selects Three Miners for Filon Fast-Track Designation - Investing News NetworkInvesting News Network · Mon, 27 Jul 2026 07:00:00 GMT